Arabic Arabic English English French French German German
dark

Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds

The anti-HIV drug lopinavir-ritonavir does not improve survival of patients with covid-19 in hospital, according to new findings from the UK RECOVERY trial.Announcing the results, which are yet to be…

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Alcohol: WHO tells Europe to raise prices to reduce harm

Next Post

Why memory-forming neurons are vulnerable to Alzheimer’s

Related Posts
Total
0
Share